Prevalence of antibodies against hepatitis C virus in the adult German population

European Journal of Gastroenterology and Hepatology

Volumn 11, Issue 11, 1999, Pages 1215-1220

  Palitzsch, Klaus Dieter ^a   Hottenträger, Barbara ^a   Schlottmann, Klaus ^a   Frick, Egbert ^a   Holstege, Axel ^a   Schölmerich, Jürgen ^a   Jilg, Wolfgang ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

Anti HCV prevalence; Germany; Hepatitis C; Normal population

Indexed keywords

CORE PROTEIN; HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; VIRUS ANTIBODY;

ADULT; AGED; ARTICLE; BLOOD DONOR; CITY; DEVICE; DISEASE MARKER; ENZYME IMMUNOASSAY; FEMALE; GENOTYPE; GERMANY; GROUPS BY AGE; HEPATITIS B; HEPATITIS C; HEPATITIS C VIRUS; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; SEROLOGY; SEX DIFFERENCE; STATISTICAL ANALYSIS; VIRUS INFECTION;

EID: 0032731985     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042737-199911000-00005     Document Type: Article

References (25)

1. Caspari G, Gerlich WH, Beyer J, Schmitt H. Age, sex and transaminase dependency of specific and nonspecific results from enzyme immunoassays for antibodies to hepatitis C virus and follow-up of blood donors. Infusionsther Transfusionsmed 1995; 22:208-219.
2. Glück D, Maurer C, Kubanek B. Studie des Berufsverbands Deutscher Transfusionsmediziner/Robert Koch-Instituts zur Epidemiologie von HIV- und Hepatitisinfektionen bei Blutspendern. In: Transfusionsmedizin 1996/97. Beitr Infusionsther Transfusionsmed. Sibrowski W, Stangel W, Müller N (editors). 1997; 34:1-4.
3. Kuo G, Choo QL, Alter HJ, Gitnick GL, Redeker AG, Purcell RH, et al. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 1989; 244:362-364.
4. Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B hepatitis genome. Science 1989; 244:359-362.
5. Alter HJ. Transmission patterns in hepatitis C virus infection. In: Viral Hepatitis and Liver Disease. Proceedings of the International Symposium on Viral Hepatitis and Liver Disease, Tokyo 1993. Nishioka K, Suzuki H, Mishiro S, Ode T (editors). Tokyo: Springer; 1994. pp. 445-449.
6. Diekamp U, Kamutzky K, Windel CD. Anti-HCV-Prävalenz und -Inzidenz bei 2,8 Millionen niedersächsischen Blutspendern - transfusionsassoziiertes HCV-Restrisiko. In: Transfusionsmedizin 1996/97. Beitr Infusionsther Transfusionsmed. Sibrowski W, Stangel W, Müller N (editors). 1997; 34:5-10.
7. Chriske HW, Rossa A. Hepatitis-C-Infektionsgefährdung des medizinischen Personals. In: Arbeitsmedizin im Gesundheitsdienst, Band 5. Hofmann F, Stößel U (editors). Stuttgart: Gentner; 1991. pp. 121-125.
8. Polywka SR, Laufs R. Hepatitis C virus antibodies among different groups at risk and patients with suspected non-A, non-B hepatitis. Infection 1991; 19:81-84.
9. Jochen AB. Occupationally acquired hepatitis C virus infection. Lancet 1992; 339:304.
10. Berthold H, Hofmann F, Michaelis M, Neumann-Haefelin D, Steinert G, Wölfle J. Hepatitis-C-Risiko für Beschäftigte im Gesundheitsdienst. In: Arbeitsmedizin im Gesundheitsdienst, Band 7. Hofmann F, Reschauer G, Stößel U (editors). Freiburg: Edition FFAS: 1994; pp. 62-66.
11. Schlipköter U, Gladziwa U, Chomalkov K, Weise A, Rasshofer R, Lorbeer B, et al. Prevalence of hepatitis C virus infections in dialysis patients and their contacts using a second generation enzyme-linked immunosorbent assay. Med Microbiol Immunol 1992; 181:173-180.
12. Stark K, Schreier E, Müller R, Wirth D, Driesel G, Bienzle U. Prevalence and determinants of anti-HCV seropositivity and of HCV genotypes among intravenous drug users in Berlin. Scand J Infect Dis 1995; 27:331-337.
13. Palitzsch KD, Nusser J, Arndt H, Enger I, Zietz B, Hügl S, et al. Diabetesepidemiologie 1998 - die Prävalenz des Diabetes mellitus und assoziierter Erkrankungen wird in Deutschland deutlich unterschätzt. Eine bundesweite Studie mit dem Diabetomobil. Diabetes und Stoffwechsel 1999 (in press).
14. Müller R. The natural history of hepatitis C: clinical experiences. J Hepatol 1996; 24(Suppl 2):52-54.
15. Anonymous. Hepatitis C: global prevalence. Weekly Epidem Record 1997; 72:341-344.
16. Suarez A, Viejo G, Navascues CA, Garcia R, Diaz G, Saro C, Roman FJ. The prevalence of hepatitis A, B and C viral markers in the population of Gijon between 26 and 65 years old. Gastroenterol Hepatol 1997; 20:347-352.
17. Sacristan B, Gastanares MI, Elena A, Sacristan M, Barcenilla J, Garcia JC, Yanguela J. Seroepidemiologic study of hepatitis C virus infection in a general population from the region of La Rioja, Spain. Med Clin (Barcelona) 1996; 107:331-335.
18. Dubois F, Desenclos JC, Mariotte N, Goudeau A. Hepatitis C in a French population-based survey, 1994: seroprevalence, frequency of viremia, genotype distribution, and risk factors. The Collaborative Study Group. Hepatology 1997; 25:1490-1496.
19. Beutels M, Van Damme P, Aelvoet W, Desmyter J, Dondeyne F, Goilav C, et al. Prevalence of hepatitis A, B and C in the Flemish population. Eur J Epidemiol 1997; 13:275-280.
20. Roure C. Overview of epidemiology and disease burden of hepatitis B in the European region. Vaccine 1995; 13(suppl. 1):S18-S21.
21. Dittmann S, Roggendorf M, Dürkop J, Wiese M, Lorbeer B, Deinhardt F. Longterm persistence of hepatitis C virus antibodies in a single source outbreak. J Hepatol 1991; 13:323-327.
22. Meisel H. Hepatitis-C-Virus. In: Virusdiagnostik. Porstmann T (editor). Berlin: Blackwell; 1996. pp. 145-187.
23. Zibert A, Roggendorf M. Molekularbiologie des Hepatitis-C-Virus. In: Hepatitis C. Häussinger D, Niederau C (editors). Berlin: Blackwell; 1997. pp. 13-51.
24. Piazza M, Sagliocca L, Tosone G, Guadagnino V, Stazi MA, Orlando R, et al. Sexual transmission of the hepatitis C virus and efficacy of prophylaxis with intramuscular immune serum globulin. Arch Intern Med 1997; 157:1537-1544.
25. Jilg W, Sieger E, Zachoval R, Schäzl H. Individuals with antibodies against hepatitis B core antigen as the only serological marker for hepatitis B infection: high percentage of carriers of hepatitis B and C virus. J Hepatol 1995; 23:14-20.